Sat, Aug 23, 2014, 5:35 AM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Sanofi Message Board

coachzack 8 posts  |  Last Activity: Jul 26, 2014 6:29 PM Member since: Jan 24, 2004
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • coachzack coachzack Jul 26, 2014 6:29 PM Flag

    GSK is smart. They will buy out a promising company like CUR for what will turnout to be a very cheap cost and as a result have therapies for Als, dementia, depression, spinal cord injury and stroke. Cur is the most inexpensive route to participate in what portends to be an major change in the approach to medicine ... cure it rather than mitigate the symptoms. China is already on board big time. Hopefully GSK knows the future is in regenerative medicine and not mitigation of symptoms. We shall see.

  • Reply to

    Shelf Offering -- Read Between the Lines

    by mmbuddha Jun 6, 2014 9:53 PM
    coachzack coachzack Jun 6, 2014 10:11 PM Flag

    Reasoning is coherent. Thanks for sharing.

  • The low volume and the drop followed by and initial modest recovery suggests that the Feuerstein attach may well meet with serious resistance. Data always speaks louder than words. The truth is and the data supports a future for CUR treatments. Soon the USA will come to understand that regenerative medicine is the paradigm of the future. In the long run it saves money and more importantly, it liberates people to fulfill their destiny and not be slaves to mitigating drugs that only prolong the agony. My son introduced me to this stock. He is smart beyond his years but to his credit he is a humanist before a capitalist. His financial support for CUR is directed toward the humanistic goals of eliminating (not reducing symptoms) for age related dementia, depression, stroke, neurological injury/disability. It takes a certain kind of person to attach companies that aspire for just noble goals. Hopefully the investors that are drawn to CUR will stand up to Feuerstein attacks and see this mission through to its natural destiny. Hopefully that destiny does provide the new hope and life to those afflicted with these heretofore untreatable diseases. As always, our best the patients and their supportive family that have courageously participated in our scientific pursuits.

  • Reply to

    HereWe Go Again

    by tommsel1 Jun 4, 2014 12:40 PM
    coachzack coachzack Jun 4, 2014 3:04 PM Flag

    This is what happen as day traders surrender their profits. A lot of shares were picked up around $3.25 by traders who live by a model that depends on the movement of money. They are not to be denigrated for using a proven model but they should be understood. When we have absorbed this genre of trade then CUR which migrate to the price suggested by the very recent positive news. At some point a new higher base will be established until the next material event which will move the shares again.

  • coachzack coachzack Jun 1, 2014 9:58 PM Flag

    I was not sure the original reference was in fact for neural stems cells. Thanks for the clarification.

  • coachzack coachzack Jun 1, 2014 9:38 PM Flag

    Please clarify if these are the same stem cells being used for the successful trials run by neurlstem. Please provide a URL for the article. Thanks
    Back To Board

  • coachzack coachzack Jun 1, 2014 9:37 PM Flag

    Please clarify if these are the same stem cells being used for the successful trials run by neurlstem. Please provide a URL for the article. Thanks

  • Reply to

    Shorts are hurting today!!

    by goldseverum May 28, 2014 1:07 PM
    coachzack coachzack May 28, 2014 7:29 PM Flag

    The latest data showed a small reduction of short interest as of 5/15/2014. Only around a 250,000 share reduction occurred. Some recent shorts may have decided to cover and sustain a wash sale designation. Probably not a lot. If all goes well by 6/16/2014 the shorts may make a more significant coverage effort. Today was just positive movement by current investors and some newcomers. The sellers were probably some longs that picked up some unbelievably cheap shares at $3.05 or so and with the buys may have exceeded their comfort holdings zone. And of course, the day traders who are happy to turn this quick profit were trading today. When we hit $5.25 I think the seed of a short squeeze will be in place. Hopefully the share price continues a steady measured climb to a new fair value of $7.00 - $8.00. To those who held through the storm ... well done :)

52.68-1.06(-1.97%)Aug 22 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.